2546 J . Org. Chem., Vol. 61, No. 7, 1996
Notes
3.23 (s, 3H), 2.90 (d, 1H, J ) 10.2 Hz); 13C NMR (CDCl3) δ
173.24, 162.14, 145.63, 131.55, 128.72, 127.94, 126.58, 123.03,
114.23, 70.99, 70.35, 56.03, 51.96, 51.87; IR (KBr) 3412, 3030,
2950, 1718, 1606 cm-1; CIMS m/z (rel intensity) 496 (M+ + H,
7), 243 (100). Anal. Calcd for C31H29NO5: C, 75.13; H, 5.91; N,
2.84. Found: C, 75.11; H, 5.73; N, 2.75.
128.27, 128.13, 105.98, 66.95, 52.79; IR (KBr) 3412, 1742, 1500
cm-1; CIMS (NH3) m/z (rel intensity) 253 (M+ + NH4, 100), 236
(M+ + H, 19); HRMS calcd for C12H14NO4 (M+ + H), 236.092283;
found 236.091810.
Data for 8: [R]25D +38.0° (c 0.67, CH2Cl2); 1H NMR (CDCl3) δ
8.27 (dd, 2H, J ) 1.8, 7.0 Hz), 8.13 (dd, 2H, J ) 2.2, 7.0 Hz),
7.35 (s, 5H), 5.64 (br d, 1H, J ) 7.7 Hz), 5.13 (s, 2H), 4.81 (m,
1H), 4.69 (m, 2H), 3.81 (s, 3H); 13C NMR (CDCl3) δ 169.66,
164.11, 155.64, 150.77, 135.88, 134.64, 130.81, 128.57, 128.35,
128.16, 123.66, 67.37, 65.37, 53.34, 53.05; IR (KBr) 3424, 1754,
1730, 1718, 1536 cm-1; ESMS m/z (rel intensity) 403 (M+ + H,
100). Anal. Calcd for C19H18N2O8: C, 56.72; H, 4.52; N, 6.96.
Found: C, 56.53; H, 4.58; N, 6.83.
Mitsu n obu Rea ction betw een N-Cbz-L-Ser in e Meth yl
Ester (6) a n d P h th a lim id e. The reaction was performed as
described in the general procedure. Starting with N-Cbz-L-
Serine methyl ester (6) (443.2 mg, 1.7 mmol), phthalimide (382.5
mg, 2.6 mmol), PPh3 (505.8 mg, 1.9 mmol), and DEAD (0.31 mL,
1.9 mmol) gave the â-elimination product 7 (301.6 mg, 1.3 mmol,
73%) and the substitution product 11B (87 mg, 0.22 mmol, 13%).
Data for 7: See above.
Data for 11B: [R]25D +12.0° (c 0.22, CH2Cl2); 1H NMR (CDCl3)
δ 7.84 (m, 2H), 7.73 (m, 2H), 7.31 (s, 5H), 5.69 (br d, 1H, J ) 7.3
Hz), 5.07 (s, 2H), 4.68 (br q, 1H, J ) 5.5 Hz), 4.22-4.04 (m, 2H),
3.79 (s, 3H); 13C NMR (CDCl3) δ 170.13, 168.02, 155.70, 136.06,
134.11, 131.65, 128.34, 127.98, 127.91, 123.46, 66.95, 53.27,
52.80, 39.03; IR (KBr) 3312, 1772, 1752, 1726, 1684 cm-1; CIMS
(NH3) m/z (rel intensity) 400 (M+ + NH4, 100), 383 (M+ + H,
27); HRMS calcd for C20H19N2O6 (M+ + H), 383.124312; found
383.125009.
N-(Tr iph en ylm eth yl)azir idin e-(2S)-car boxylic acid m eth -
1
yl ester (14): [R]25 -85.9° (c 0.09, CH2Cl2); H NMR (CDCl3)
D
δ 7.51-7.19 (m, 15H), 3.76 (s, 3H), 2.26 (dd, 1H, J ) 1.4, 2.6
Hz), 1.89 (dd, 1H, J ) 2.6, 6.2 Hz), 1.41 (dd, 1H, J ) 1.4, 6.2
Hz); 13C NMR (CDCl3) δ 172.20, 143.53, 129.24, 128.98, 128.55,
128.36, 127.90, 127.83, 127.75, 127.56, 126.84, 126.55, 74.30,
51.98, 31.61, 28.57; IR (KBr) 3434, 3060, 1744, 1490, 1448, 1284,
1242 cm-1; CIMS m/z (rel intensity) 344 (M+ + H, 21), 243 (100);
HRMS calcd for C23H22NO2 (M+ + H), 344.1650; found 344.1664.
N-(9-P h en ylflu or en -9-yl)-O-(4-ca r bom eth oxyp h en yl)-L-
ser in e m eth yl ester (11G): [R]25 -62.5° (c 0.11, CH2Cl2); 1H
D
NMR (CDCl3) δ 7.90 (dd, 2H, J ) 1.8, 8.8 Hz), 7.69 (t, 2H, J )
6.6 Hz), 7.44-7.16 (m, 11H), 6.71 (dd, 2H, J ) 2.2, 9.1 Hz), 4.00
(dd, 1H, J ) 5.1, 9.5 Hz), 3.92 (dd, 1H, J ) 2.9, 6.6 Hz), 3.87 (s,
3H), 3.36 (s, 3H), 3.20 (br d, 1H, J ) 8.8 Hz), 3.05 (m, 1H); 13C
NMR (CDCl3) δ 174.06, 166.66, 161.97, 148.90, 148.46, 143.99,
140.88, 140.07, 131.39, 128.46, 128.24, 127.94, 127.54, 127.29,
126.00, 125.71, 125.05, 122.78, 120.07, 119.96, 114.06, 72.74,
70.00, 54.94, 51.83, 51.72; IR (film) 3320, 2950, 1716 cm-1; ESMS
m/z (rel intensity) 494 (M+ + H, 41), 241 (100). Anal. Calcd for
C
31H27NO5: C, 75.44; H, 5.51; N, 2.85. Found: C, 75.57; H, 5.41;
N, 2.80.
N-9-P h en ylflu or en -9-yla zir id in e-(2S)-ca r b oxylic a cid
m eth yl ester (15): [R]25 -124.1° (c 0.94, CH2Cl2); 1H NMR
D
(CDCl3) δ 7.69 (td, 2H, J ) 2.5, 4.8 Hz), 7.41-7.33 (m, 4H), 7.28-
7.18 (m, 7H), 3.69 (s, 3H), 2.19 (dd, 1H, J ) 2.9, 6.2 Hz), 2.09
(dd, 1H, J ) 1.1, 2.9 Hz), 1.55 (dd, 1H, J ) 1.1, 6.2 Hz); 13C
NMR (CDCl3) δ 171.40, 147.24, 146.05, 142.95, 141.20, 140.29,
128.90, 128.71, 128.25, 127.77, 127.64, 127.14, 126.90, 126.21,
126.23, 119.95, 119.90, 75.72, 52.11, 33.18, 29.76; IR (KBr) 3058,
1748, 1448 cm-1; HRMS calcd for C23H20NO2 (M+ + H),
342.149404; found 342.147554.
Mitsu n obu Rea ction betw een N-Boc-L-Ser in e Ben zyl
Ester (en tr y E) a n d Meth yl 4-Hyd r oxyben zoa te. The
reaction was performed as described in the general procedure.
Starting with N-Boc-L-serine benzyl ester (517.7 mg, 1.7 mmol),
methyl 4-hydroxybenzoate (399.4 mg, 2.6 mmol), PPh3 (505.8
mg, 1.9 mmol), and DEAD (0.31 mL, 1.9 mmol) gave the
â-elimination product 12 (442.5 mg, 1.6 mmol, 91%): 1H NMR
(CDCl3) δ 7.37 (m, 5H), 7.03 (br s, 1H), 6.17 (br s, 1H), 5.79 (d,
1H, J ) 1.5 Hz), 5.26 (s, 2H), 1.48 (s, 9H); 13C NMR (CDCl3) δ
163.86, 152.53, 135.21, 131.38, 128.63, 128.50, 128.18, 105.43,
80.67, 67.60, 28.23; IR (KBr) 3456, 3420, 2978, 1718 cm-1; HRMS
calcd for C15H20NO4 (M+ + H), 278.139233; found 278.138973.
Mitsu n obu Rea ction betw een N-Cbz-L-Ser in e Meth yl
Ester (6) a n d 4-Nitr oben zoic Acid . The reaction was per-
formed as described in the general procedure. Starting with
N-Cbz-L-serine methyl ester (6) (283.0 mg, 1.1 mmol), 4-ni-
trobenzoic acid (280.2 mg, 1.7 mmol), PPh3 (322.5 mg, 1.2 mmol),
and DEAD (0.19 mL, 1.2 mmol) gave the â-elimination product
7 (141 mg, 0.6 mmol, 53%) and the substitution product 8 (126
mg, 0.3 mmol, 28%).
Ack n ow led gm en t. The authors would like to thank
Professor Henry Rapoport and Dr. Arthur D. Patten for
informative discussions.
Data for 7: 1H NMR (CDCl3) δ 7.37 (m, 5H), 7.24 (br s, 1H),
6.25 (br s, 1H), 5.79 (d, 1H, J ) 1.5 Hz), 5.16 (s, 2H), 3.83 (s,
3H); 13C NMR (CDCl3) δ 164.07, 153.02, 135.76, 130.91, 128.51,
J O951958T